CNDO-109

Fortress Biotech Presents Positive Data from the Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia
Yahoo
Wed, 05/18/16 - 11:18 am
Fortress Biotech
clinical trials
CNDO-109
acute myeloid leukemia
Pipeline Progress at Coronado Biosciences
Yahoo/Zacks.com
Mon, 04/14/14 - 09:29 pm
Coronado Biosciences
CNDO-109
autism
Coronado Biosciences Reuniting Old Friends
Seeking Alpha
Fri, 07/5/13 - 10:40 am
Coronado Biosciences
CNDO-201
CNDO-109
Crohn's Disease
Multiple Myeloma
acute myeloid leukemia
Coronado Biosciences initiates Phase 1/2 trial of CNDO-109
Yahoo/Fly on the Wall
Wed, 11/28/12 - 10:56 am
CNDO-109
Coronado Biosciences
acute myeloid leukemia
Coronado Biosciences: Provides Investors With 2 Distinct Pipelines And Significant Market Potential
Seeking Alpha
Sun, 04/1/12 - 12:18 pm
Coronado Biosciences
Crohn's Disease
ulcerative colitis
multiple sclerosis
OvaMed
CNDO-109
acute myeloid leukemia